BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6197419)

  • 1. Cellular localization of keratin in proliferative epithelial processes and neoplasms of the human ovary.
    Davis BW; Morassi LL; Locher GW; Wetherall N; Grigolato P
    J Cancer Res Clin Oncol; 1983; 106(3):222-8. PubMed ID: 6197419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate filaments in rat ovarian surface epithelial cells: changes with neoplastic progression in culture.
    Hornby AE; Pan J; Auersperg N
    Biochem Cell Biol; 1992 Jan; 70(1):16-25. PubMed ID: 1374615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common epithelial ovarian tumors. Immunohistochemical intermediate filament profiles.
    Dabbs DJ; Geisinger KR
    Cancer; 1988 Jul; 62(2):368-74. PubMed ID: 2454722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of cytokeratins and vimentin in common epithelial tumours of the ovary: an immunocytochemical study of eighty-three cases.
    Viale G; Gambacorta M; Dell'Orto P; Coggi G
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(2):91-101. PubMed ID: 2455381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM; Meir A; Sabo E
    Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
    van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
    Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical distribution of monoclonal antibodies against keratin in papillomas and carcinomas from oral and nasopharyngeal regions.
    Nakai M; Mori M
    Oral Surg Oral Med Oral Pathol; 1986 Sep; 62(3):292-302. PubMed ID: 2427988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytokeratin profiles of ovarian common "epithelial" tumors.
    Duggan MA; Robertson DI
    Eur J Gynaecol Oncol; 1989; 10(2):73-9. PubMed ID: 2470591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
    Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
    Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases.
    Truong LD; Maccato ML; Awalt H; Cagle PT; Schwartz MR; Kaplan AL
    Hum Pathol; 1990 Jan; 21(1):99-110. PubMed ID: 1688545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in expression of differentiation markers between normal ovarian cells and derived tumors.
    Van Niekerk CC; Ramaekers FC; Hanselaar AG; Aldeweireldt J; Poels LG
    Am J Pathol; 1993 Jan; 142(1):157-77. PubMed ID: 7678716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary.
    Wauters CC; Smedts F; Gerrits LG; Bosman FT; Ramaekers FC
    Hum Pathol; 1995 Aug; 26(8):852-5. PubMed ID: 7543441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of a Mr 52,000 keratin in basal epithelial cells of the mouse bladder and expression throughout neoplastic progression.
    Summerhayes IC; Chen LB
    Cancer Res; 1982 Oct; 42(10):4098-109. PubMed ID: 6179596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytokeratins 7 and 20 in ovarian neoplasia.
    Cathro HP; Stoler MH
    Am J Clin Pathol; 2002 Jun; 117(6):944-51. PubMed ID: 12047147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
    Bell KA; Kurman RJ
    Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of keratin-type proteins in epithelial neoplasms. Correlation with electron microscopic findings.
    Espinoza CG; Azar HA
    Am J Clin Pathol; 1982 Oct; 78(4):500-7. PubMed ID: 6182789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
    Prat J
    Mod Pathol; 2005 Feb; 18 Suppl 2():S99-111. PubMed ID: 15492758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective expression of cytokeratin polypeptides in various epithelia of human Brenner tumor.
    Lifschitz-Mercer B; Czernobilsky B; Shezen E; Dgani R; Leitner O; Geiger B
    Hum Pathol; 1988 Jun; 19(6):640-50. PubMed ID: 2454213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.